Answers are grounded in this paper and cite their sources.
Rationale: Enterobacter cloacae is an exceptionally rare cause of cardiac implantable electronic device-infective endocarditis. Only 9 previous cases have been reported previously in the literature. We report on the 10th case with the aim of updating the current knowledge. Patient concerns: An 84-year-old woman with a history of complete heart block status post–cardiac resynchronization therapy-pacemaker (CRT-P) placement, presented with fevers, chills, and rigors for 1 day duration and 3 days of fatigue. On examination, there were no signs of local infection over the pacemaker. Diagnoses: Blood cultures grew E cloacae , and the transesophageal echocardiogram confirmed echo densities on the ventricular and atrial lead of CRT-P. Interventions: The CRT-P was replaced with a leadless pacemaker on day 3 after diagnosis and was initially treated with intravenous meropenem while inpatient then switched to ertapenem for a total duration of 6 weeks from device explanation. Outcomes: The patient’s symptoms improved, and she had no relapses of infection. Lessons: Cardiac device endocarditis should be in the differential for patients with E cloacae bacteremia in the absence of pocket infection. Early CRT-P device removal helps to prevent relapses of infection.
No takes yet. Share an insight, caveat, or question.
Guru et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: